Medical device management system

Information

  • Patent Grant
  • 11596363
  • Patent Number
    11,596,363
  • Date Filed
    Thursday, March 10, 2016
    8 years ago
  • Date Issued
    Tuesday, March 7, 2023
    a year ago
Abstract
The present disclosure provides systems and methods for calibrating medical devices and processing physiological measurements using a medical device management system. As an example, the medical device can be a handheld glucometer configured for invasive testing and non-invasive testing of physiological parameters of a patient.
Description
RELATED APPLICATIONS INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are incorporated by reference under 37 CFR 1.57 and made a part of this specification.


BACKGROUND

Medical device manufacturers are continually increasing the processing capabilities of physiological monitors that process signals based upon the attenuation of light by a tissue site. In general, such physiological monitoring systems include one or more optical sensors that irradiate a tissue site and one or more photodetectors that detect the optical radiation after attenuation by the tissue site. The sensor communicates the detected signal to a physiological monitor, which removes noise and preprocesses the signal. Advanced signal processors then perform time domain and/or frequency domain processing to determine blood constituents and other physiological parameters.


Manufacturers have advanced basic pulse oximeters from devices that determine measurements for blood oxygen saturation (SpO2), pulse rate (PR) and plethysmographic information to read-through-motion oximeters and to cooximeters that determine measurements of many constituents of circulating blood. For example, Masimo Corporation of Irvine Calif. (“Masimo”) manufactures pulse oximetry systems including Masimo SET® low noise optical sensors and read through motion pulse oximetry monitors for measuring SpO2, PR and perfusion index (PI). Masimo optical sensors include any of Masimo LNOp®, LNCS®, SofTouch™ and Blue™ adhesive or reusable sensors. Masimo pulse oximetry monitors include any of Masimo Rad-8®, Rad-5®, Rad®-5v or SatShare® monitors. Such advanced pulse oximeters and low noise sensors have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios.


Many innovations improving the measurement of blood constituents are described in at least U.S. Pat. Nos. 6,770,028; 6,658,276; 6,157,850; 6,002,952; 5,769,785 and 5,758,644, which are assigned to Masimo and are incorporated by reference herein. Corresponding low noise optical sensors are disclosed in at least U.S. Pat. Nos. 6,985,764; 6,088,607; 5,782,757 and 5,638,818, assigned to Masimo and hereby incorporated in their entirety by reference herein.


Advanced blood parameter measurement systems include Masimo Rainbow® SET, which provides measurements in addition to SpO2, such as total hemoglobin (SpHb™), oxygen content (SpOC™), methemoglobin (SpMet®), carboxyhemoglobin (SpCO®) and PVI®. Advanced blood parameter sensors include Masimo Rainbow® adhesive, ReSposable™ and reusable sensors. Advanced blood parameter monitors include Masimo Radical-7™, Rad87™ and Rad57™ monitors, all available from Masimo. Advanced parameter measurement systems mayaiso include acoustic monitoring such as acoustic respiration rate (RRa™) using a Rainbow Acoustic Sensor™ and Rad87™ monitor, available from Masimo. Such advanced pulse oximeters, low noise sensors and advanced parameter systems have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios. An advanced parameter measurement system that includes acoustic monitoring is described in U.S. Pat. Pub. No. 2010/0274099, filed Dec. 21, 2009, titled Acoustic Sensor Assembly, assigned to Masimo and incorporated in its entirety by reference herein.


Innovations relating to other advanced blood parameter measurement systems are described in at least U.S. Pat. No. 7,647,083, filed Mar. 1, 2006, titled Multiple Wavelength Sensor Equalization; U.S. Pat. No. 7,729,733, filed Mar. 1, 2006, titled Configurable Physiological Measurement System; U.S. Pat. Pub. No. 2006/0211925, filed Mar. 1, 2006, titled Physiological Parameter Confidence Measure and U.S. Pat. Pub. No. 2006/0238358, filed Mar. 1, 2006, titled Noninvasive Multi-Parameter Patient Monitor, all assigned to Cercacor Laboratories, Inc., Irvine, Calif. (Cercacor) and all incorporated in their entirety by reference herein.


SUMMARY

In some embodiments the present disclosure provides a method for processing physiological measurements. The method including receiving, by a medical device management system, physiological measurement data from a portable medical device. The physiological measurement data includes identification information associated with a user of the portable medical device. The method also includes identifying a user account of the medical device management system based on identification data, processing the physiological measurement data to determine at least one physiological parameter associated with the physiological measurement data, transmitting the determined at least one physiological parameter to the portable medical device for display, and storing the physiological measurement data and the determined at least one physiological parameter in the identified user account.


In some embodiments the present disclosure provides a method for calibrating a portable medical device. The method includes receiving a request for calibration from a portable medical device. The request includes identification information associated with the medical device. The method further includes identifying an account associated with the medical device based on the identification information, determining that the device needs calibration based on the information stored in the account, sending a signal to the medical device to initiate a calibration mode on the medical device, receiving calibration data from the medical device, processing the calibration data to determine a calibration of the device, transmitting an updated calibration to medical device, and storing the updated calibration in the account associated with the medical device.


In some embodiments the present disclosure provides a medical device management system including a data store and a computing device. The data store can be configured to store user account information associated with a plurality of user accounts. The computing device is in communication with the data store and can be configured to receive a measurement request from a portable medical device. The measurement request can include physiological measurement data. The computing device can be further configured to identify a user account of the plurality of user accounts associated with the measurement request, process the physiological measurement data to determine at least one physiological parameter associated with the physiological measurement data, transmit the determined at least one physiological parameter to the portable medical device for display and storing the physiological measurement data and the determined at least one physiological parameter in the identified user account.


For purposes of summarizing the invention, certain aspects, advantages and novel features of the invention have been described herein. Of course, it is to be understood that not necessarily all such aspects, advantages or features will be embodied in any particular embodiment of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing aspects and many of the attendant advantages will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings:



FIG. 1 illustrates a block diagram depicting an illustrative embodiment of an operating environment for a medical device management system.



FIG. 2 illustrates a perspective view of an embodiment of a handheld glucometer.



FIG. 3 illustrates an end view of the embodiment of the handheld glucometer from FIG. 2.



FIG. 4 illustrates an opposite end view of the embodiment of the handheld glucometer from FIG. 2.



FIG. 5 illustrates an exploded view of the embodiment of the handheld glucometer from FIG. 2.



FIG. 6 illustrates a method of updating the calibration of a medical device using a medical device management system.





DETAILED DESCRIPTION


FIG. 1 illustrates an embodiment of an operating environment 100 for a medical device management system 110. The operating environment includes a medical device management system 110 configured to communicate with a plurality of medical devices 130 and 140 over a network 102. The medical device management system 110 can also be referred to as a network-based or cloud-based management system.


Those skilled in the art will appreciate that the communication network 102 may be any wired network, wireless network or combination thereof. In addition, the communication network 102 may be a personal area network, local area network, wide area network, cable network, satellite network, cellular telephone network, or combination thereof. Protocols and components for communicating via the Internet or any of the other aforementioned types of communication networks are well known to those skilled in the art of computer communications and thus, need not be described in more detail herein.


In this embodiment, the medical device management system 110 includes an account management module 112, an algorithm processing module 114, an interface module 116, and a data collection module 118. The medical device management system 110 is in communication with a data store 120. The data store 120 can store data received from the medical devices 130 and 140.


In general, the word module, as used herein, refers to logic embodied in hardware or firmware, or to a collection of software instructions stored on a non-transitory, tangible computer-readable medium, possibly having entry and exit points, written in a programming language, such as, for example, C, C++, C#, or Java. A software module may be compiled and linked into an executable program, installed in a dynamic link library, or may be written in an interpreted programming language such as, for example, BASIC, Perl, or Python. It will be appreciated that software modules may be callable from other modules or from themselves, and/or may be invoked in response to detected events or interrupts. Software modules may be stored in any type of computer-readable medium, such as a memory device (e.g., random access, flash memory, and the like), an optical medium (e.g., a CD, DVD, BluRay, and the like), firmware (e.g., an EPROM), or any other storage medium. The software modules may be configured for execution by one or more CPUs in order to cause the medical device management system 110 to perform particular operations.


It will be further appreciated that hardware modules may be comprised of connected logic units, such as gates and flip-flops, and/or may be comprised of programmable units, such as programmable gate arrays or processors. The modules described herein are preferably implemented as software modules, but may be represented in hardware or firmware. Generally, the modules described herein refer to logical modules that may be combined with other modules or divided into sub-modules despite their physical organization or storage.


The medical devices 130 and 140 can be configured to measure and record physiological signals from a user. The physiological signals including, but not limited to, blood pressure (diastolic), blood pressure (systolic), PR, glucose, total hemoglobin (SpHb), SpO2, PI, venous oxygen saturation (SpVO2), pleth variability index (PVI), SpCHOL, SpBUN, SpHDL, and/or other physiological parameters.


The medical devices 130 and 140 can have an associated sensor, such as an optical sensor, to monitor physiological parameters. One example of an optical sensor is described in detail with respect to U.S. patent application Ser. No. 13/646,659 titled Noninvasive Blood Analysis System, filed Oct. 5, 2012, assigned to Cercacor and incorporated in its entirety by reference herein. A blood glucose monitor is described in detail with respect to U.S. patent application Ser. No. 13/308,461 titled Handheld Processing Device Including Medical Applications for Minimally and Noninvasive Glucose Measurements, filed Nov. 30, 2011, assigned to Cercacor and incorporated in its entirety by reference herein. A blood glucose monitor and sensor are described in detail with respect to U.S. patent application Ser. No. 13/473,477 titled Personal Health Device, filed May 16, 2012, assigned to Cercacor and incorporated in its entirety by reference herein. A blood glucose calibration system is described in detail with respect to U.S. patent application Ser. No. 13/726,539 titled Blood Glucose Calibration System, filed Dec. 24, 2012, assigned to Cercacor and incorporated in its entirety by reference herein.


The medical devices 130 and 140 can communicate with the medical device management system 110 via the network 102. In some embodiments, a medical device can be a network-capable device, such as medical device 130. The medical device 130 can be configured to communicate directly with the medical device management system 110. The medical device 130 can have an interface module 160 configured to manage communication between the medical device management system 110 and the medical device 130. The interface module 160 can be specific to the medical device 130 and each type of medical device can have a different interface module 160. Some medical devices, such as medical device 140, communicate with the medical device management system 110 via a host computing device 150.


The computing device 150 can correspond to a wide variety of devices or components that are capable of initiating, receiving or facilitating communications over the communication network 102 including, but not limited to, personal computing devices, hand held computing devices, integrated components for inclusion in computing devices, smart phones, modems, personal digital assistants, laptop computers, media devices, and the like.


The computing device 150 can have an interface module 160 that can be configured to interface with the medical device management system 110. The interface module 160 can be configured to provide a user with access to the medical device management system 110. The interface module 160 can be an application that operates on the computing device 150. The application can be configured to recognize the medical device 140 when the device is in communication with the computing device 150. The interface module 160 can be used when the medical device 140 is not capable of communicating directly with the medical device management system 110 over the network. The medical device 140 can communicate with the interface module 160 via a physical connection to a computing device 150 (e.g., a USB connection) or using wireless communication protocols (e.g., WiFi, Bluetooth, etc.).


The interface module 160 can be configured to communicate with the medical device management system and provide and receive information from the medical device. The information provided by the medical device to the medical device management system 110 can include information such as device serial number, calibration information, synchronization information, biometric data, and other types of data or information. For simplicity, reference will generally be made to the medical device 130 when describing interactions between a medical device and the medical device management system 110. The functionality described with relation to medical device 130 can be implemented on medical device 140, either directly or through another computing device. Depending on the specific type of medical device, none, some or all of the features and functionality discussed herein may be implemented locally on the medical device.


The medical device management system 110 can include a user portal and a back end infrastructure. The medical device management system 110 can store, organize and present medical data collected by the medical device to the user. The account management module 112 can manage the user accounts in the medical device management system 110. The algorithm processing module 114 can be configured to utilize algorithms to dynamically and quickly determine blood constituent values that would not be calculable locally on a portable medical device. The interface module 116 can be configured to interface with the medical devices 130 and 140 via the respective device-side interface modules 160. The interface module 116 can also be configured to manage a web-based interface. Further, the interface module 116 can be responsible for synchronization of the medical with the medical device management system 110. The interface module 116 can also be responsible for uploading data to the medical device management system 110. The data collection module 118 can store, organize and present medical data collected by the devices to the users and interface with the data store 120.


The medical device management system 110 can utilize an account-based management system. Each user can set up a user account that can be associated with one or more medical devices. The user can provide information during an account registration process, such as demographic information, age, gender, date of birth, height, weight, credit card information, and/or other user information.


Users can interact with the medical device management system 110 to initialize, configure, synchronize and manage their medical devices. The medical device management system 110 can perform data processing of the medical data collected from the medical devices. When a user has registered their medical device(s) to their user account on the medical device management system 110, the user can have access to medical data collected by their medical device. Each user can use the medical device management system 110 as a portal through which they can monitor and manage their medical data over time. The medical device management system 110 can sort through the user's data and present it in relevant views (such as monthly trends, yearly trends, after meal trends, etc.). In some embodiments, the user can personalize the medical device, such as creating a name for the device, selecting the language of the device, privacy settings, alarms, thresholds, and other options. The privacy settings can allow the user to choose whether to share their data with others. For example, the user can choose not to share the data, or the user can share the data with others, such as with their family, their doctor, and/or everyone.


Prior to use, the interface module 160 communicate with the medical device management system to initialize and configure the medical device 130 and synchronize the medical device 130 with a user's personal account within the medical device management system 110. After configuration, the medical device can be registered and synced to the user's medical device management system account and data collected on medical device can be synchronized and uploaded to the user's medical device management system account. In some embodiments, a user can access the medical device and make configuration settings for the medical device via a web interface by logging in to the medical device management system. Changes made to the configuration settings in the web interface can be pushed to the medical device during a synchronization procedure. For example, if there is a change detected, the interface module 160 can retrieve the configuration table from medical device management system 110 and apply the configuration to the connected device. Identification information associated with a user account and/or user device can be used to associate the physiological measurement data received from a device with a user account. The identification information can include information such as a user ID, device ID (e.g., serial number), user credentials, tokens, or other types of information that can be used by the medical device management system. For example, when the medical device management system receives physiological data, the data could include identification information that can be used to identify the user account and/or device associated with the physiological measurement data.


In one embodiment of the initialization process, the interface module 160 can retrieve identification information or data such as, user credentials, device ID (e.g., serial number), and/or other required and/or relevant information from the device. The information can be sent to the medical device management system 110. The receipt of information by the medical device management system 110 from the medical device 130 can trigger the medical device management system 110 to provide an authentication token to the medical device 130. The authentication token can be provided to the medical device 130 via the interface module 160, which can be stored on the device for authentication and identification purposes.


The medical device management system 110 can be configured to allow multiple users to use the same medical device. One user can be designated as the device administrator within the medical device management system 110. After the medical device is registered and initialized for use by a device administrator, additional users can be associated with the medical device. The additional users can use the medical device and have their personal medical data managed on a separate user account with the medical device management system 110. In some embodiments, an administrator can grant additional users access by sending an invitation via their medical device management system account. An unregistered user (e.g., guest user) may still be able to use the medical device, however, the medical device management system may not store and track the unregistered user's data.


A medical device that has been registered can synchronize the data stored on the medical device with the medical device management system 110. The interface module 160 can retrieve the physiological data from the medical device and send it to the medical device management system 110. The medical device management system can store the physiological data in the data store 120. The stored data can be retrieved and sorted by the user.


Data sent from the medical device to the medical device management system 110 can trigger creation of a file with information associated with the physiological data. In one embodiment the file can include, a timestamp, a location of a binary file (raw physiological data), and location that an output file should be stored.


Online Data Processing


The medical device management system 110 can provide massive computing capability in the cloud for many users and devices. The increased computing power can be used to run increasingly more complex algorithms as well as supporting multiple devices simultaneously. The algorithms running on the medical device management system 110 can be updated. The version and specifics of the algorithm can also be traceable and there can be a log of each update.


When the medical device management system 110 receives new physiological data from a medical device, it can store the data in the data store 120. The medical device management system 110 can create a reference file, such as an XML file, referencing the new physiological data and invoking the algorithm processing module 114. The reference file can provide the information necessary to access the physiological information, run the required algorithm, calculate the results (or return an error code if unable to generate a result), and then create the desired output file. The output file can include information such as measured parameters, processing time, errors that may have occurred, algorithm version, and timestamp. The medical device management system can send the results back to the device to be displayed for the user. The medical device management system can save the output results in the database for future use.


Since the medical device management system 110 can have a virtually unlimited storage capacity, more complex algorithms can be implemented which utilize a patient's historical data in order to improve future measurements. For example, a patient-unique calibration may utilize historical measurements and calibration points to reach a better accuracy. The medical device management system can store and retrieve data and filter results by device ID, User ID, date etc., so that the algorithm knows which files are relevant for each particular subject and should be used in generating a calibration.


The medical device 130 can determine whether the medical device management system 110 is ready to begin processing data. If medical device management system is not ready, the medical device can return an error after a timeout period. If the medical device management system 110 is ready, the system can begin caching resources in preparation for data processing. The device can begin collecting and streaming physiological data associated with the user to the medical device management system 110. The medical device management system 110 can process the collected data and determine one or more physiological measurements based on the physiological data. The medical device can be configured to provide the raw data to the medical device management system 110 for processing. The raw data may undergo some processing (e.g., filtering) prior to being transferred to the medical device management system. In some embodiments, the medical device 130 can be configured to determine whether there is a connection to the medical device management system 110 prior to processing the data. For example, if there is no connection, the device may process the physiological data locally. Whereas, if there is a connect to the medical device management system 110, the device can send the data to the system 110 for processing. The system can also calibrate the medical device, which will be further discussed with relation to FIG. 6. Handheld Glucometer


With reference now to FIGS. 2-5, an illustrative embodiment of a handheld medical device 200 is illustrated. The handheld medical device 200 can also be referred to as a handheld glucometer. The handheld glucometer 200 includes a housing 210, a display 220, a plurality of control buttons 230, an I/O port 240, a glucose reader 250, and a sensor connector 260.


The handheld glucometer 200 can be utilized for invasive and/or non-invasive blood glucose monitoring or non-invasive partial blood panel monitoring by home users in a non-clinical setting or trained individuals in a clinical setting. The handheld glucometer 200 can perform one or more of the following physiological measurements: invasive glucose testing, non-invasive blood glucose testing, Oxygen Saturation (SpO2), Total Hemoglobin (SpHb), Alkaline Phosphatase (SpALP), Total Cholesterol (SpChol), High-Density Lipoprotein (SpHDL), Total Cholesterol Divided by High Density Lipoprotein (SpChol/SpHDL).


The handheld glucometer 200 can perform invasive blood glucose measurements when the user lancets their finger for a capillary blood sample and places it onto a glucose test strip that is inserted into the handheld glucometer 200. The invasive blood glucose measurements can be used for at least two functions. First, the invasive measurements can be used by the handheld glucometer 200 during calibration. The handheld glucometer 200 can request that invasive calibration measurements be taken from time to time, such as during the initial use of the device in order to set a standard of calibration for the patient and the non-invasive sensor. Second, the user can take invasive measurements to test the accuracy of the non-invasive blood glucose measurements or when the user prefers to have an invasive measurement taken. The handheld glucometer 200 can help to reduce the frequency of pain associated with typical home blood glucose meters that require invasive blood draws approximately 4-7 times per day. Advantageously, with the handheld glucometer 200 a user may be able to reduce the number of invasive blood draws to 1-2 per week if they can be replaced with 4-7 non-invasive measurements per day, which can reduce the pain associated with frequent lancing and reduce the likelihood of tissue damage.


The handheld glucometer 200 can be used in conjunction with the medical device management system 110. The handheld glucometer 200 can communicate with the medical device management system 110 via a computing device 150. In some embodiments, the handheld glucometer 200 can be physically connected to the computing device 150, such as a USB connection, or a wireless connection, such as a Bluetooth connection. The computing device can be a mobile computing device such as a smart phone, or another computing device such as a desktop computer. The medical device management system 110 can allow the user to review trends and user logged variables that can contribute to highs and lows in their glucose values. The results can be shared with family, friends, and care givers.


The display 220 can display text and graphics. In one embodiment, the display 220 can be an OLED display. In one embodiment, the display 220 can have a resolution of 128×96 pixels. The display can have a viewing angle that is greater than or equal to about 45 degrees on all axes. The display 220 can have a user interface. The user interface can be configured to show a wireless connectivity state, such as a Bluetooth connection state. The user interface can be configured to show battery capacity icon with states of charge remaining and/or charge state. The user interface can display a real-time clock that can be accurate to within 10 minutes per year, which the handheld glucometer 200 can use to time stamp each test. The handheld glucometer 200 can provide the user with the option to select from available regional time zones. The user interface can track and display an average on a preconfigured number of days and can display a total number of glucose results. In some embodiments, the handheld glucometer 200 can prevent users from omitting non-invasive or invasive glucose test results.


The handheld glucometer 200 can have various operating states, such as an off mode where the processor is powered off; a low-power operating mode where the processor power is minimized, the display 220 is off, and wireless connections can be maintained; and a normal operating mode where the display 220 is on and the processor is fully operating. The handheld glucometer 200 can transition from low power mode to normal operating mode by a user press of a hard button, a user inserting an invasive strip, or a user attaching a non-invasive sensor.


The handheld glucometer 200 can have various test configurations, such as on-demand where the handheld glucometer 200 ready for an invasive glucose test when a user inserts an invasive strip in the device, or ready for a non-invasive glucose test when a user connects the non-invasive sensor. The handheld glucometer 200 can perform non-invasive measurements in less than 180 seconds (e.g., three 60 second measurements if/when necessary). The handheld glucometer 200 can perform invasive measurements in less than 10 seconds.


The handheld glucometer 200 can have a plurality of control buttons, including a “Start/Stop” button, “Plus/Minus” buttons, a “Trend Button” configured to show previous tests, a volume button configured to adjust the volume, and a wireless connectivity button. The handheld glucometer 200 can have a Micro USB connector to facilitate battery charging, data transfer of measurement data, and software upgrades.


The handheld glucometer 200 can have a glucose reader 250 comprising a shell 252 and a slot 254 for the invasive strip glucose reader. The glucose strip reader 250 can be on different side of device from sensor connector 260. The glucose strip reader 250 can facilitate invasive testing and calibration testing. The slot 254 can be illuminated to facilitate the insertion of the test strip into the slot by the user.


The handheld glucometer 200 can automatically recognize when a test strip is inserted into the slot 254. The handheld glucometer 200 can instruct a user on how to operate the device during a testing procedure. The display 220 can show a percentage complete or seconds remaining count-down during an invasive glucose measurement. The display 220 can distinguish between invasive glucose values and other measured parameters.


For non-invasive measurements, the display 220 can show a percentage complete or count-down during a measurement. The handheld glucometer 200 can have a non-invasive glucose calibration capability that has a frequency that can be automatically controlled by device and/or manually run by a user at any time. The handheld glucometer 200 can have a lock out mechanism to prevent non-invasive glucose tests if the system has not been successfully calibrated. The display 220 can distinguish between non-invasive glucose values and other measured parameters on device.


The handheld glucometer 200 can have a quality control test mode to help verify that the system is operating within specifications. In the quality control test mode, the handheld glucometer 200 tests the measurement values associated with control test strips that utilize control solutions. The control test strips have known associated test values. The handheld glucometer 200 can also have a non-invasive quality control method that permits a user or manufacturing personnel to check the validity of the non-invasive system with a rainbow parameter sensor.


The handheld glucometer 200 can have a radio interface to communicate via radio communication, such as Bluetooth 2.0-4.0 and Bluetooth low energy (BLE), in order to facilitate data transfer (measurements and physiological data), connection to a computing device, such as a mobile device. The handheld glucometer 200 has non-volatile memory, such as a non-removable MicroSD card, to maintain system software and user measurements.


The handheld glucometer 200 can have a rechargeable battery, such as a 1600 mAH Li+ battery. The handheld glucometer 220 can perform a minimum of 20 consecutive non-invasive test measurements from full charge. The handheld glucometer 200 can perform measurements while charging and charge at full rate when in low power mode. At full rate, the handheld glucometer 200 can charge the battery in less than 6 hours. The handheld glucometer 200 can operate in a standby mode for a minimum of 18 hours per full charge.


The sensor interface 260 can connect to a non-invasive sensor such as an optical sensor, such as one of the sensors described above that be connected to the medical devices 130 and 140. Some measurement values generated by a non-invasive sensor can include oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), total hemoglobin (SpHb), alkaline phosphatase (SpALP), total cholesterol (SpChol) (3406), high-density lipoprotein (SpHDL), total cholesterol divided by high density lipoprotein (SpChol/SpHDL), and non-invasive glucose (SpGlu). Other parameters can be viewable through the host device or a web application.


The handheld glucometer 200 can be user configurable by a host device (e.g., a computing device in communication with the handheld glucometer) or a website to make changes to the user interface. The user can determine a priority for non-invasive measurement and determine the display characteristics of the measurement values. The user can determine which measurement value is the default measurement after a non-invasive test is performed. The handheld glucometer 200 can have user set parameters for upper and lower limit notification control settings. The parameters can be set from the host device or a web-based interface with the medical device management system 110. The user can set restrictions on the access and notification of the previous test results stored in the medical device management system. The handheld glucometer 200 can have measurement alerts that can have a visual and/or an audio alert to notify the user when measurement levels, invasive or non-invasive, exceed a specified measurement range. The medical device management system can have a diabetes management system to display historical data and trends.


With reference now to FIG. 6, a calibration routine 600 for a medical device is illustrated. The calibration routine 200 can be performed generally by the medical device management system, and more specifically, by one or more modules of the medical device management system 110, such as the algorithm processing module 114, the interface module 116, and/or the data collection module 118. The calibration routine can be for single point calibration, multi-point calibration and/or other medical device specific calibration techniques.


At block 602, the medical device management system 110 can receive a request for calibration from the medical device 202. The medical device 130 can query the medical device management system 110 to determine whether calibration is required. The medical device 130 can query the medical device management system 110 each time measurement data is collected, after a defined number of measurements, after a determined time period, or other criteria.


At block 604, the medical device management system 110 can determine calibration of the medical device is required. The medical device management system 110 can determine that calibration is required based on the information contained in the request received from the medical device 130. In some embodiments, the medical device management system 110 determines if and when calibration is required based on previously stored data. In such cases, the medical device management system 110 may actively initiate calibration of the medical device 130 without previously receiving a request from the medical device 130. If the medical device management system 110 determines that no calibration required, data acquisition can occur as normal.


If calibration is required, at block 606, the calibration mode can be initiated on the medical device. The calibration mode can be a separate function on the device that handles communication with the medical device management system 110 independently of the data collection. The calibration mode on the medical device can be configured to lock the medical device from further use until calibration is completed. In calibration mode the medical device can send calibration data, such as measurement values, error codes, timestamps, device ID, sensor ID, and other information to the medical device management system 110. The specific calibration information required by the medical device management system 110 is dependent on the type of the device, type of calibration, and/or other device or system specific information.


In one embodiment for a non-invasive glucose calibration, the device can perform a manual entry calibration and a calibration using a built in strip reader. For manual entry calibration, the user can have the option of manually entering their glucose value into the medical device. Manual entry gives the flexibility to use a reference device other than the internal strip reader to help with calibration. For a strip reader calibration, the user can immediately measure their glucose value with a built in strip reader based on an invasive test. The device can also measure the glucose value using a non-invasive test and the values can be sent to the medical device management system 110 to calculate the results of the calibration.


At block 608, the medical device management system 110 calculates a calibration for the medical device based on the calibration data received from the medical device 130. The medical device management system 110 can determine the calibration based on the specific calibration information stored in the system. For example, a lookup table may be used to determine the calibration for the device. More advanced algorithms and patient specific calibrations may be used based on the information provided by the medical device.


The medical device management system 110 can store all of the data associated with a specific patient and a specific device, thereby allowing the system to tailor the calibration to the specific patient and the specific device. For example, a patient-unique calibration may utilize historical measurements and calibration points to reach a better accuracy. The medical device management system can store and retrieve data and filter results by device ID, User ID, date etc., so that the algorithm knows which files are relevant for each particular subject and should be used in generating the patient unique calibration. The calibration information can be stored in the data store 120, so that it can be referenced at a later time.


After the calculation of the calibration is complete, at block 610, the calibration can be updated on the medical device. The medical device management system 110 can provide the updated calibration data to the medical device 130. After updating the calibration, the medical device can transition from the calibration mode to measurement mode, which can allow the user to perform measurements as required. The calibration routine ends at block 612.


In addition to those processes described above, other processes and combination of processes will be apparent to those of skill in the art from the present disclosure. Those of skill will further appreciate that the various illustrative logical blocks, modules, and steps described in connection with the embodiments disclosed herein may be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. Skilled artisans can implement the described functionality in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the present invention.


The various illustrative logical blocks, modules, and steps described in connection with the embodiments disclosed herein can be implemented or performed with a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, conventional processor, controller, microcontroller, state machine, etc. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. In addition, the term “processing” is a broad term meant to encompass several meanings including, for example, implementing program code, executing instructions, manipulating signals, filtering, performing arithmetic operations, and the like.


The modules can include, but are not limited to, any of the following: software or hardware components such as software, object-oriented software components, class components and task components, processes, methods, functions, attributes, procedures, subroutines, segments of program code, drivers, firmware, microcode, circuitry, data, databases, data structures, tables, arrays, or variables.


The steps of a method or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, a DVD, or any other form of storage medium known in the art. A storage medium is coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.


Although the foregoing invention has been described in terms of certain preferred embodiments, other embodiments will be apparent to those of ordinary skill in the art from the disclosure herein. Additionally, other combinations, omissions, substitutions and modifications will be apparent to the skilled artisan in view of the disclosure herein. It is contemplated that various aspects and features of the invention described can be practiced separately, combined together, or substituted for one another, and that a variety of combinations and subcombinations of the features and aspects can be made and still fall within the scope of the invention. Furthermore, the systems described above need not include all of the modules and functions described in the preferred embodiments. Accordingly, the present invention is not intended to be limited by the reaction of the preferred embodiments, but is to be defined by reference to the appended claims.


Additionally, all publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.

Claims
  • 1. A method for processing physiological measurements, the method comprising: automatically initiating, by a medical device management system, a calibration mode on a portable medical device based on an analysis of physiological measurement data received from the portable medical device, wherein, after the initiation of the calibration mode, the calibration mode locks the portable medical device from performing further non-invasive blood glucose measurement until calibration is completed, wherein the medical device management system communicates with the portable medical device over a wireless communication network and remotely initiates the calibration mode on the portable medical device;receiving, by the medical device management system, first physiological measurement data from a portable medical device, wherein the first physiological measurement data comprises identification information associated with a user of the portable medical device, invasive blood glucose measurement data, and non-invasive blood glucose measurement data, wherein the non-invasive blood glucose measurement data is based on data generated by an optical sensor of the portable medical device during a non-invasive glucose measurement of the user, wherein the invasive blood glucose measurement data is generated based on a user blood sample received by the portable medical device;identifying, by the medical device management system, a first user account of the medical device management system based on the identification information;processing, by the medical device management system, the first physiological measurement data to update a user specific calibration associated with the first user account, wherein the user specific calibration is based at least in part on the invasive blood glucose measurement data and the non-invasive blood glucose measurement data;providing, by the medical device management system, an indication to the portable medical device that calibration is complete, wherein the portable medical device transitions to a measurement mode;after completion of the calibration, receiving, by the medical device management system, second physiological measurement data from the portable medical device, the second physiological measurement data comprising identification information associated with the first user account and second non-invasive blood glucose measurement data;processing, by the medical device management system, the second physiological measurement data to determine a first non-invasive blood glucose measurement associated with the first non-invasive blood glucose measurement data based at least in part on the user specific calibration associated with the first user account;transmitting, by the medical device management system, the first non-invasive blood glucose measurement to the portable medical device for display; andstoring, by the medical device management system, the second physiological measurement data and the first non-invasive blood glucose measurement in the first user account.
  • 2. The method of claim 1 further comprising providing the first non-invasive blood glucose measurement to a user account different from the first user account based on one or more privacy settings of the identified user account.
  • 3. The method of claim 1, wherein the medical device is a glucometer.
  • 4. The method of claim 1, wherein the physiological measurement data comprises non-invasive physiological measurement data.
  • 5. The method of claim 1, wherein the physiological measurement data comprises invasive physiological test data.
  • 6. The method of claim 1, wherein the physiological measurement data is contained in an XML file.
  • 7. A medical device management system comprising: a data store configured to store user account information associated with a plurality of user accounts; anda computing device in communication with the data store, the computing device configured to: automatically initiate a calibration mode on a portable medical device based on an analysis of physiological measurement data received from the portable medical device, wherein, after the initiation of the calibration mode, the calibration mode locks the portable medical device from performing further non-invasive blood glucose measurement until calibration is completed, wherein the medical device management system communicates with the portable medical device over a wireless communication network and remotely initiates the calibration mode on the portable medical device;receive first physiological measurement data including invasive blood glucose measurement data and non-invasive blood glucose measurement data, wherein the non-invasive blood glucose measurement data is based on data generated by an optical sensor of the portable medical device during a non-invasive glucose measurement of a user, wherein the invasive blood glucose measurement data is generated based on a user blood sample received by the portable medical device;identify a first user account of the plurality of user accounts associated with the measurement request;process the first physiological measurement data to update a user specific calibration associated with the first user account, wherein the user specific calibration is based at least in part on the invasive blood glucose measurement data and the non-invasive blood glucose measurement data;provide an indication to the portable medical device that calibration is complete, wherein the portable medical device transitions to a measurement mode;after completion of the calibration, receive, by the medical device management system, second physiological measurement data from the portable medical device, the second physiological measurement data comprising identification information associated with the first user account and second non-invasive blood glucose measurement data;process the second physiological measurement data to determine a first non-invasive blood glucose measurement associated with the physiological measurement data based at least in part on a user specific calibration associated with the first user account;transmit the first non-invasive blood glucose measurement to the portable medical device for display; andstore the physiological measurement data and the first non-invasive blood glucose measurement in the first user account.
  • 8. The system of claim 7, wherein the physiological measurement data comprises measurement data associated with at least one or more additional physiological parameters including at least one of invasive glucose testing, Oxygen Saturation (SpO2), Total Hemoglobin (SpHb), Alkaline Phosphatase (SpALP), Total Cholesterol (SpChol), High-Density Lipoprotein (SpHDL), or Total Cholesterol Divided by High Density Lipoprotein (SpChol/SpHDL).
  • 9. The system of claim 7, wherein the user account stores a log of all measurements and calibrations associated with each user account.
  • 10. The system of claim 7, wherein the data store is further configured to store device profile information associated with a plurality of device profiles and the computing device is further configured to identify a device profile of the plurality of device profiles based on identification information.
  • 11. The system of claim 10, wherein multiple users are associated with the same device profile.
US Referenced Citations (1098)
Number Name Date Kind
4960128 Gordon et al. Oct 1990 A
4964408 Hink et al. Oct 1990 A
5041187 Hink et al. Aug 1991 A
5069213 Polczynski Dec 1991 A
5163438 Gordon et al. Nov 1992 A
5319355 Russek Jun 1994 A
5337744 Branigan Aug 1994 A
5341805 Stavridi et al. Aug 1994 A
D353195 Savage et al. Dec 1994 S
D353196 Savage et al. Dec 1994 S
5377676 Vari et al. Jan 1995 A
D359546 Savage et al. Jun 1995 S
5431170 Mathews Jul 1995 A
5436499 Namavar et al. Jul 1995 A
D361840 Savage et al. Aug 1995 S
D362063 Savage et al. Sep 1995 S
5452717 Branigan et al. Sep 1995 A
D363120 Savage et al. Oct 1995 S
5456252 Vari et al. Oct 1995 A
5479934 Imran Jan 1996 A
5482036 Diab et al. Jan 1996 A
5490505 Diab et al. Feb 1996 A
5494043 O'Sullivan et al. Feb 1996 A
5533511 Kaspari et al. Jul 1996 A
5534851 Russek Jul 1996 A
5561275 Savage et al. Oct 1996 A
5562002 Lalin Oct 1996 A
5590649 Caro et al. Jan 1997 A
5602924 Durand et al. Feb 1997 A
5632272 Diab et al. May 1997 A
5638816 Kiani-Azarbayjany et al. Jun 1997 A
5638818 Diab et al. Jun 1997 A
5645440 Tobler et al. Jul 1997 A
5671914 Kalkhoran et al. Sep 1997 A
5685299 Diab et al. Nov 1997 A
5726440 Kalkhoran et al. Mar 1998 A
D393830 Tobler et al. Apr 1998 S
5743262 Lepper, Jr. et al. Apr 1998 A
5747806 Khalil et al. May 1998 A
5750994 Schlager May 1998 A
5758644 Diab et al. Jun 1998 A
5760910 Lepper, Jr. et al. Jun 1998 A
5769785 Diab et al. Jun 1998 A
5782757 Diab et al. Jul 1998 A
5785659 Caro et al. Jul 1998 A
5791347 Flaherty et al. Aug 1998 A
5810734 Caro et al. Sep 1998 A
5823950 Diab et al. Oct 1998 A
5830131 Caro et al. Nov 1998 A
5833618 Caro et al. Nov 1998 A
5860919 Kiani-Azarbayjany et al. Jan 1999 A
5890929 Mills et al. Apr 1999 A
5904654 Wohltmann et al. May 1999 A
5919134 Diab Jul 1999 A
5934925 Tobler et al. Aug 1999 A
5940182 Lepper, Jr. et al. Aug 1999 A
5987343 Kinast Nov 1999 A
5995855 Kiani et al. Nov 1999 A
5997343 Mills et al. Dec 1999 A
6002952 Diab et al. Dec 1999 A
6010937 Karam et al. Jan 2000 A
6011986 Diab et al. Jan 2000 A
6027452 Flaherty et al. Feb 2000 A
6036642 Diab et al. Mar 2000 A
6040578 Malin et al. Mar 2000 A
6045509 Caro et al. Apr 2000 A
6066204 Haven May 2000 A
6067462 Diab et al. May 2000 A
6081735 Diab et al. Jun 2000 A
6088607 Diab et al. Jul 2000 A
6110522 Lepper, Jr. et al. Aug 2000 A
6115673 Malin et al. Sep 2000 A
6124597 Shehada et al. Sep 2000 A
6128521 Marro et al. Oct 2000 A
6129675 Jay Oct 2000 A
6144868 Parker Nov 2000 A
6151516 Kiani-Azarbayjany et al. Nov 2000 A
6152754 Gerhardt et al. Nov 2000 A
6157850 Diab et al. Dec 2000 A
6165005 Mills et al. Dec 2000 A
6184521 Coffin et al. Feb 2001 B1
6206830 Diab et al. Mar 2001 B1
6229856 Diab et al. May 2001 B1
6232609 Snyder et al. May 2001 B1
6236872 Diab et al. May 2001 B1
6241683 Macklem et al. Jun 2001 B1
6253097 Aronow et al. Jun 2001 B1
6255708 Sudharsanan et al. Jul 2001 B1
6256523 Diab et al. Jul 2001 B1
6263222 Diab et al. Jul 2001 B1
6278522 Lepper, Jr. et al. Aug 2001 B1
6280213 Tobler et al. Aug 2001 B1
6280381 Malin et al. Aug 2001 B1
6285896 Tobler et al. Sep 2001 B1
6301493 Marro et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6317627 Ennen et al. Nov 2001 B1
6321100 Parker Nov 2001 B1
6325761 Jay Dec 2001 B1
6334065 Al-Ali et al. Dec 2001 B1
6343224 Parker Jan 2002 B1
6349228 Kiani et al. Feb 2002 B1
6360114 Diab et al. Mar 2002 B1
6368283 Xu et al. Apr 2002 B1
6371921 Caro et al. Apr 2002 B1
6377829 Al-Ali Apr 2002 B1
6388240 Schulz et al. May 2002 B2
6397091 Diab et al. May 2002 B2
6411373 Garside et al. Jun 2002 B1
6415167 Blank et al. Jul 2002 B1
6430437 Marro Aug 2002 B1
6430525 Weber et al. Aug 2002 B1
6463311 Diab Oct 2002 B1
6470199 Kopotic et al. Oct 2002 B1
6487429 Hockersmith et al. Nov 2002 B2
6501975 Diab et al. Dec 2002 B2
6505059 Kollias et al. Jan 2003 B1
6515273 Al-Ali Feb 2003 B2
6519487 Parker Feb 2003 B1
6525386 Mills et al. Feb 2003 B1
6526300 Kiani et al. Feb 2003 B1
6534012 Hazen et al. Mar 2003 B1
6541756 Schulz et al. Apr 2003 B2
6542764 Al-Ali et al. Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6584336 Ali et al. Jun 2003 B1
6587196 Stippick et al. Jul 2003 B1
6587199 Luu Jul 2003 B1
6595316 Cybulski et al. Jul 2003 B2
6597932 Tian et al. Jul 2003 B2
6597933 Kiani et al. Jul 2003 B2
6606511 Ali et al. Aug 2003 B1
6632181 Flaherty et al. Oct 2003 B2
6635559 Greenwald et al. Oct 2003 B2
6639668 Trepagnier Oct 2003 B1
6640116 Diab Oct 2003 B2
6640117 Makarewicz et al. Oct 2003 B2
6643530 Diab et al. Nov 2003 B2
6650917 Diab et al. Nov 2003 B2
6654624 Diab et al. Nov 2003 B2
6658276 Diab et al. Dec 2003 B2
6661161 Lanzo et al. Dec 2003 B1
6671531 Al-Ali et al. Dec 2003 B2
6678543 Diab et al. Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6684091 Parker Jan 2004 B2
6697656 Al-Ali Feb 2004 B1
6697657 Shehada et al. Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
RE38476 Diab et al. Mar 2004 E
6699194 Diab et al. Mar 2004 B1
6714804 Al-Ali et al. Mar 2004 B2
RE38492 Diab et al. Apr 2004 E
6721582 Trepagnier et al. Apr 2004 B2
6721585 Parker Apr 2004 B1
6725075 Al-Ali Apr 2004 B2
6728560 Kollias et al. Apr 2004 B2
6735459 Parker May 2004 B2
6738652 Mattu et al. May 2004 B2
6745060 Diab et al. Jun 2004 B2
6760607 Al-Ali Jul 2004 B2
6770028 Ali et al. Aug 2004 B1
6771994 Kiani et al. Aug 2004 B2
6788965 Ruchti et al. Sep 2004 B2
6792300 Diab et al. Sep 2004 B1
6813511 Diab et al. Nov 2004 B2
6816241 Grubisic Nov 2004 B2
6816741 Diab Nov 2004 B2
6822564 Al-Ali Nov 2004 B2
6826419 Diab et al. Nov 2004 B2
6830711 Mills et al. Dec 2004 B2
6850787 Weber et al. Feb 2005 B2
6850788 Al-Ali Feb 2005 B2
6852083 Caro et al. Feb 2005 B2
6861639 Al-Ali Mar 2005 B2
6876931 Lorenz et al. Apr 2005 B2
6898452 Al-Ali et al. May 2005 B2
6920345 Al-Ali et al. Jul 2005 B2
6931268 Kiani-Azarbayjany et al. Aug 2005 B1
6934570 Kiani et al. Aug 2005 B2
6939305 Flaherty et al. Sep 2005 B2
6943348 Coffin IV Sep 2005 B1
6950687 Al-Ali Sep 2005 B2
6956649 Acosta et al. Oct 2005 B2
6961598 Diab Nov 2005 B2
6970792 Diab Nov 2005 B1
6979812 Al-Ali Dec 2005 B2
6985764 Mason et al. Jan 2006 B2
6990364 Ruchti et al. Jan 2006 B2
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
6999904 Weber et al. Feb 2006 B2
7003338 Weber et al. Feb 2006 B2
7003339 Diab et al. Feb 2006 B2
7015451 Dalke et al. Mar 2006 B2
7024233 Ali et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7030749 Al-Ali Apr 2006 B2
7039449 Al-Ali May 2006 B2
7041060 Flaherty et al. May 2006 B2
7044918 Diab May 2006 B2
7048687 Reuss et al. May 2006 B1
7067893 Mills et al. Jun 2006 B2
D526719 Richie, Jr. et al. Aug 2006 S
7096052 Mason et al. Aug 2006 B2
7096054 Abdul-Hafiz et al. Aug 2006 B2
D529616 Deros et al. Oct 2006 S
7132641 Schulz et al. Nov 2006 B2
7133710 Acosta et al. Nov 2006 B2
7142901 Kiani et al. Nov 2006 B2
7149561 Diab Dec 2006 B2
7186966 Al-Ali Mar 2007 B2
7190261 Al-Ali Mar 2007 B2
7215984 Diab et al. May 2007 B2
7215986 Diab et al. May 2007 B2
7221971 Diab et al. May 2007 B2
7225006 Al-Ali et al. May 2007 B2
7225007 Al-Ali et al. May 2007 B2
RE39672 Shehada et al. Jun 2007 E
7239905 Kiani-Azarbayjany et al. Jul 2007 B2
7245953 Parker Jul 2007 B1
7254429 Schurman et al. Aug 2007 B2
7254431 Al-Ali et al. Aug 2007 B2
7254433 Diab et al. Aug 2007 B2
7254434 Schulz et al. Aug 2007 B2
7272425 Al-Ali Sep 2007 B2
7274955 Kiani et al. Sep 2007 B2
D554263 Al-Ali Oct 2007 S
7280858 Al-Ali et al. Oct 2007 B2
7289835 Mansfield et al. Oct 2007 B2
7292883 De Felice et al. Nov 2007 B2
7295866 Al-Ali Nov 2007 B2
7328053 Diab et al. Feb 2008 B1
7332784 Mills et al. Feb 2008 B2
7340287 Mason et al. Mar 2008 B2
7341559 Schulz et al. Mar 2008 B2
7343186 Lamego et al. Mar 2008 B2
D566282 Al-Ali et al. Apr 2008 S
7355512 Al-Ali Apr 2008 B1
7356365 Schurman Apr 2008 B2
7371981 Abdul-Hafiz May 2008 B2
7373193 Al-Ali et al. May 2008 B2
7373194 Weber et al. May 2008 B2
7376453 Diab et al. May 2008 B1
7377794 Al-Ali et al. May 2008 B2
7377899 Weber et al. May 2008 B2
7383070 Diab et al. Jun 2008 B2
7395158 Monfre et al. Jul 2008 B2
7415297 Al-Ali et al. Aug 2008 B2
7428432 Ali et al. Sep 2008 B2
7438683 Al-Ali et al. Oct 2008 B2
7440787 Diab Oct 2008 B2
7454240 Diab et al. Nov 2008 B2
7467002 Weber et al. Dec 2008 B2
7469157 Diab et al. Dec 2008 B2
7471969 Diab et al. Dec 2008 B2
7471971 Diab et al. Dec 2008 B2
7483729 Al-Ali et al. Jan 2009 B2
7483730 Diab et al. Jan 2009 B2
7489958 Diab et al. Feb 2009 B2
7496391 Diab et al. Feb 2009 B2
7496393 Diab et al. Feb 2009 B2
D587657 Al-Ali et al. Mar 2009 S
7499741 Diab et al. Mar 2009 B2
7499835 Weber et al. Mar 2009 B2
7500950 Al-Ali et al. Mar 2009 B2
7509154 Diab et al. Mar 2009 B2
7509494 Al-Ali Mar 2009 B2
7510849 Schurman et al. Mar 2009 B2
7514725 Wojtczuk et al. Apr 2009 B2
7519406 Blank et al. Apr 2009 B2
7526328 Diab et al. Apr 2009 B2
D592507 Wachman et al. May 2009 S
7530942 Diab May 2009 B1
7530949 Al Ali et al. May 2009 B2
7530955 Diab et al. May 2009 B2
7563110 Al-Ali et al. Jul 2009 B2
7593230 Abul-Haj et al. Sep 2009 B2
7596398 Al-Ali et al. Sep 2009 B2
7606608 Blank et al. Oct 2009 B2
7618375 Flaherty et al. Nov 2009 B2
7620674 Ruchti et al. Nov 2009 B2
D606659 Kiani et al. Dec 2009 S
7629039 Eckerbom et al. Dec 2009 B2
7640140 Ruchti et al. Dec 2009 B2
7647083 Al-Ali et al. Jan 2010 B2
D609193 Al-Ali et al. Feb 2010 S
D614305 Al-Ali et al. Apr 2010 S
7697966 Monfre et al. Apr 2010 B2
7698105 Ruchti et al. Apr 2010 B2
RE41317 Parker May 2010 E
RE41333 Blank et al. May 2010 E
7729733 Al-Ali et al. Jun 2010 B2
7734320 Al-Ali Jun 2010 B2
7761127 Al-Ali et al. Jul 2010 B2
7761128 Al-Ali et al. Jul 2010 B2
7764982 Dalke et al. Jul 2010 B2
D621516 Kiani et al. Aug 2010 S
7791155 Diab Sep 2010 B2
7801581 Diab Sep 2010 B2
7822452 Schurman et al. Oct 2010 B2
RE41912 Parker Nov 2010 E
7844313 Kiani et al. Nov 2010 B2
7844314 Al-Ali Nov 2010 B2
7844315 Al-Ali Nov 2010 B2
7865222 Weber et al. Jan 2011 B2
7873497 Weber et al. Jan 2011 B2
7880606 Al-Ali Feb 2011 B2
7880626 Al-Ali et al. Feb 2011 B2
7891355 Al-Ali et al. Feb 2011 B2
7894868 Al-Ali et al. Feb 2011 B2
7899507 Al-Ali et al. Mar 2011 B2
7899518 Trepagnier et al. Mar 2011 B2
7904132 Weber et al. Mar 2011 B2
7909772 Popov et al. Mar 2011 B2
7910875 Al-Ali Mar 2011 B2
7919713 Al-Ali et al. Apr 2011 B2
7937128 Al-Ali May 2011 B2
7937129 Mason et al. May 2011 B2
7937130 Diab et al. May 2011 B2
7941199 Kiani May 2011 B2
7951086 Flaherty et al. May 2011 B2
7957780 Lamego et al. Jun 2011 B2
7962188 Kiani et al. Jun 2011 B2
7962190 Diab et al. Jun 2011 B1
7976472 Kiani Jul 2011 B2
7988637 Diab Aug 2011 B2
7990382 Kiani Aug 2011 B2
7991446 Al-Ali et al. Aug 2011 B2
8000761 Al-Ali Aug 2011 B2
8008088 Bellott et al. Aug 2011 B2
RE42753 Kiani-Azarbayjany et al. Sep 2011 E
8019400 Diab et al. Sep 2011 B2
8028701 Al-Ali et al. Oct 2011 B2
8029765 Bellott et al. Oct 2011 B2
8036727 Schurman et al. Oct 2011 B2
8036728 Diab et al. Oct 2011 B2
8046040 Ali et al. Oct 2011 B2
8046041 Diab et al. Oct 2011 B2
8046042 Diab et al. Oct 2011 B2
8048040 Kiani Nov 2011 B2
8050728 Al-Ali et al. Nov 2011 B2
RE43169 Parker Feb 2012 E
8118620 Al-Ali et al. Feb 2012 B2
8126528 Diab et al. Feb 2012 B2
8128572 Diab et al. Mar 2012 B2
8130105 Al-Ali et al. Mar 2012 B2
8145287 Diab et al. Mar 2012 B2
8150487 Diab et al. Apr 2012 B2
8175672 Parker May 2012 B2
8180420 Diab et al. May 2012 B2
8182443 Kiani May 2012 B1
8185180 Diab et al. May 2012 B2
8190223 Al-Ali et al. May 2012 B2
8190227 Diab et al. May 2012 B2
8203438 Kiani et al. Jun 2012 B2
8203704 Merritt et al. Jun 2012 B2
8204566 Schurman et al. Jun 2012 B2
8219172 Schurman et al. Jul 2012 B2
8224411 Al-Ali et al. Jul 2012 B2
8228181 Al-Ali Jul 2012 B2
8229532 Davis Jul 2012 B2
8229533 Diab et al. Jul 2012 B2
8233955 Al-Ali et al. Jul 2012 B2
8244325 Al-Ali et al. Aug 2012 B2
8255026 Al-Ali Aug 2012 B1
8255027 Al-Ali et al. Aug 2012 B2
8255028 Al-Ali et al. Aug 2012 B2
8260577 Weber et al. Sep 2012 B2
8265723 McHale et al. Sep 2012 B1
8274360 Sampath et al. Sep 2012 B2
8280473 Al-Ali Oct 2012 B2
8301217 Al-Ali et al. Oct 2012 B2
8306596 Schurman et al. Nov 2012 B2
8310336 Muhsin et al. Nov 2012 B2
8315683 Al-Ali et al. Nov 2012 B2
RE43860 Parker Dec 2012 E
8337403 Al-Ali et al. Dec 2012 B2
8346330 Lamego Jan 2013 B2
8353842 Al-Ali et al. Jan 2013 B2
8355766 MacNeish, III et al. Jan 2013 B2
8359080 Diab et al. Jan 2013 B2
8364223 Al-Ali et al. Jan 2013 B2
8364226 Diab et al. Jan 2013 B2
8374665 Lamego Feb 2013 B2
8385995 Al-Ali et al. Feb 2013 B2
8385996 Dalke et al. Feb 2013 B2
8388353 Kiani et al. Mar 2013 B2
8399822 Al-Ali Mar 2013 B2
8401602 Kiani Mar 2013 B2
8405608 Al-Ali et al. Mar 2013 B2
8414499 Al-Ali et al. Apr 2013 B2
8418524 Al-Ali Apr 2013 B2
8423106 Lamego et al. Apr 2013 B2
8428967 Olsen et al. Apr 2013 B2
8430817 Al-Ali et al. Apr 2013 B1
8437825 Dalvi et al. May 2013 B2
8455290 Siskavich Jun 2013 B2
8457703 Al-Ali Jun 2013 B2
8457707 Kiani Jun 2013 B2
8463349 Diab et al. Jun 2013 B2
8466286 Bellott et al. Jun 2013 B2
8471713 Poeze et al. Jun 2013 B2
8473020 Kiani et al. Jun 2013 B2
8483787 Al-Ali et al. Jul 2013 B2
8489364 Weber et al. Jul 2013 B2
8498684 Weber et al. Jul 2013 B2
8504128 Blank et al. Aug 2013 B2
8509867 Workman et al. Aug 2013 B2
8515509 Bruinsma et al. Aug 2013 B2
8523781 Al-Ali Sep 2013 B2
8529301 Al-Ali et al. Sep 2013 B2
8532727 Al-Ali et al. Sep 2013 B2
8532728 Diab et al. Sep 2013 B2
D692145 Al-Ali et al. Oct 2013 S
8547209 Kiani et al. Oct 2013 B2
8548548 Al-Ali Oct 2013 B2
8548549 Schurman et al. Oct 2013 B2
8548550 Al-Ali et al. Oct 2013 B2
8560032 Al-Ali et al. Oct 2013 B2
8560034 Diab et al. Oct 2013 B1
8570167 Al-Ali Oct 2013 B2
8570503 Vo et al. Oct 2013 B2
8571617 Reichgott et al. Oct 2013 B2
8571618 Lamego et al. Oct 2013 B1
8571619 Al-Ali et al. Oct 2013 B2
8584345 Al-Ali et al. Oct 2013 B2
8577431 Lamego et al. Nov 2013 B2
8581732 Al-Ali et al. Nov 2013 B2
8588880 Abdul-Hafiz et al. Nov 2013 B2
8600467 Al-Ali et al. Dec 2013 B2
8606342 Diab Dec 2013 B2
8626255 Al-Ali et al. Jan 2014 B2
8630691 Lamego et al. Jan 2014 B2
8634889 Al-Ali et al. Jan 2014 B2
8641631 Sierra et al. Feb 2014 B2
8652060 Al-Ali Feb 2014 B2
8663107 Kiani Mar 2014 B2
8666468 Al-Ali Mar 2014 B1
8667967 Al-Ali et al. Mar 2014 B2
8670811 O'Reilly Mar 2014 B2
8670814 Diab et al. Mar 2014 B2
8676286 Weber et al. Mar 2014 B2
8682407 Al-Ali Mar 2014 B2
RE44823 Parker Apr 2014 E
RE44875 Kiani et al. Apr 2014 E
8688183 Bruinsma et al. Apr 2014 B2
8690799 Telfort et al. Apr 2014 B2
8700112 Kiani Apr 2014 B2
8702627 Telfort et al. Apr 2014 B2
8706179 Parker Apr 2014 B2
8712494 MacNeish, III et al. Apr 2014 B1
8715206 Telfort et al. May 2014 B2
8718735 Lamego et al. May 2014 B2
8718737 Diab et al. May 2014 B2
8718738 Blank et al. May 2014 B2
8720249 Al-Ali May 2014 B2
8721541 Al-Ali et al. May 2014 B2
8721542 Al-Ali et al. May 2014 B2
8723677 Kiani May 2014 B1
8740792 Kiani et al. Jun 2014 B1
8754776 Poeze et al. Jun 2014 B2
8755535 Telfort et al. Jun 2014 B2
8755856 Diab et al. Jun 2014 B2
8755872 Marinow Jun 2014 B1
8761850 Lamego Jun 2014 B2
8764671 Kiani Jul 2014 B2
8768423 Shakespeare et al. Jul 2014 B2
8771204 Telfort et al. Jul 2014 B2
8777634 Kiani et al. Jul 2014 B2
8781543 Diab et al. Jul 2014 B2
8781544 Al-Ali et al. Jul 2014 B2
8781549 Al-Ali et al. Jul 2014 B2
8788003 Schurman et al. Jul 2014 B2
8790268 Al-Ali Jul 2014 B2
8801613 Al-Ali et al. Aug 2014 B2
8821397 Al-Ali et al. Sep 2014 B2
8821415 Al-Ali et al. Sep 2014 B2
8830449 Lamego et al. Sep 2014 B1
8831700 Schurman et al. Sep 2014 B2
8840549 Al-Ali et al. Sep 2014 B2
8852094 Al-Ali et al. Oct 2014 B2
8852994 Wojtczuk et al. Oct 2014 B2
8897847 Al-Ali Nov 2014 B2
8911377 Al-Ali Dec 2014 B2
8989831 Al-Ali et al. Mar 2015 B2
8998809 Kiani Apr 2015 B2
9066666 Kiani Jun 2015 B2
9066680 Al-Ali et al. Jun 2015 B1
9095316 Welch et al. Aug 2015 B2
9106038 Telfort et al. Aug 2015 B2
9107625 Telfort et al. Aug 2015 B2
9131881 Diab et al. Sep 2015 B2
9138180 Coverston et al. Sep 2015 B1
9153112 Kiani et al. Oct 2015 B1
9192329 Al-Ali Nov 2015 B2
9192351 Telfort et al. Nov 2015 B1
9195385 Al-Ali et al. Nov 2015 B2
9211095 Al-Ali Dec 2015 B1
9218454 Kiani et al. Dec 2015 B2
9245668 Vo et al. Jan 2016 B1
9267572 Barker et al. Feb 2016 B2
9277880 Poeze et al. Mar 2016 B2
9307928 Al-Ali et al. Apr 2016 B1
9323894 Kiani Apr 2016 B2
D755392 Hwang et al. May 2016 S
9326712 Kiani May 2016 B1
9351673 Diab et al. May 2016 B2
9351675 Al-Ali et al. May 2016 B2
9364181 Kiani et al. Jun 2016 B2
9368671 Wojtczuk et al. Jun 2016 B2
9370325 Al-Ali et al. Jun 2016 B2
9370326 McHale et al. Jun 2016 B2
9370335 Al-ali et al. Jun 2016 B2
9375185 Ali et al. Jun 2016 B2
9386953 Al-Ali Jul 2016 B2
9386961 Al-Ali et al. Jul 2016 B2
9392945 Al-Ali et al. Jul 2016 B2
9397448 Al-Ali et al. Jul 2016 B2
9408542 Kinast et al. Aug 2016 B1
9436645 Al-Ali et al. Sep 2016 B2
9445759 Lamego Sep 2016 B1
9466919 Kiani et al. Oct 2016 B2
9474474 Lamego et al. Oct 2016 B2
9480422 Al-Ali Nov 2016 B2
9480435 Olsen Nov 2016 B2
9492110 Al-Ali et al. Nov 2016 B2
9510779 Poeze et al. Dec 2016 B2
9517024 Kiani et al. Dec 2016 B2
9532722 Lamego et al. Jan 2017 B2
9538949 Al-Ali et al. Jan 2017 B2
9538980 Telfort et al. Jan 2017 B2
9549696 Lamego et al. Jan 2017 B2
9554737 Schurman et al. Jan 2017 B2
9560996 Kiani Feb 2017 B2
9560998 Al-Ali et al. Feb 2017 B2
9566019 Al-Ali et al. Feb 2017 B2
9579039 Jansen et al. Feb 2017 B2
9591975 Dalvi et al. Mar 2017 B2
9622692 Lamego et al. Apr 2017 B2
9622693 Diab Apr 2017 B2
D788312 Al-Ali et al. May 2017 S
9636055 Al-Ali et al. May 2017 B2
9636056 Al-All May 2017 B2
9649054 Lamego et al. May 2017 B2
9662052 Al-Ali et al. May 2017 B2
9668679 Schurman et al. Jun 2017 B2
9668680 Bruinsma et al. Jun 2017 B2
9668703 Al-Ali Jun 2017 B2
9675286 Diab Jun 2017 B2
9687160 Kiani Jun 2017 B2
9693719 Al-Ali et al. Jul 2017 B2
9693737 Al-Ali Jul 2017 B2
9697928 Al-Ali et al. Jul 2017 B2
9717425 Kiani et al. Aug 2017 B2
9717458 Lamego et al. Aug 2017 B2
9724016 Al-Ali et al. Aug 2017 B1
9724024 Al-Ali Aug 2017 B2
9724025 Kiani et al. Aug 2017 B1
9730640 Diab et al. Aug 2017 B2
9743887 Al-Ali et al. Aug 2017 B2
9749232 Sampath et al. Aug 2017 B2
9750442 Olsen Sep 2017 B2
9750443 Smith et al. Sep 2017 B2
9750461 Telfort Sep 2017 B1
9775545 Al-Ali et al. Oct 2017 B2
9775546 Diab et al. Oct 2017 B2
9775570 Al-All Oct 2017 B2
9778079 Al-Ali et al. Oct 2017 B1
9782077 Lamego et al. Oct 2017 B2
9782110 Kiani Oct 2017 B2
9787568 Lamego et al. Oct 2017 B2
9788735 Al-Ali Oct 2017 B2
9788768 Al-Ali et al. Oct 2017 B2
9795300 Al-All Oct 2017 B2
9795310 Al-All Oct 2017 B2
9795358 Telfort et al. Oct 2017 B2
9795739 Al-Ali et al. Oct 2017 B2
9801556 Kiani Oct 2017 B2
9801588 Weber et al. Oct 2017 B2
9808188 Perea et al. Nov 2017 B1
9814418 Weber et al. Nov 2017 B2
9820691 Kiani Nov 2017 B2
9833152 Kiani et al. Dec 2017 B2
9833180 Shakespeare et al. Dec 2017 B2
9839379 Al-Ali et al. Dec 2017 B2
9839381 Weber et al. Dec 2017 B1
9847002 Kiani et al. Dec 2017 B2
9847749 Kiani et al. Dec 2017 B2
9848800 Lee et al. Dec 2017 B1
9848806 Al-Ali et al. Dec 2017 B2
9848807 Lamego Dec 2017 B2
9861298 Eckerbom et al. Jan 2018 B2
9861304 Al-Ali et al. Jan 2018 B2
9861305 Weber et al. Jan 2018 B1
9867578 Al-Ali et al. Jan 2018 B2
9872623 Al-All Jan 2018 B2
9876320 Coverston et al. Jan 2018 B2
9877650 Muhsin et al. Jan 2018 B2
9877686 Al-Ali et al. Jan 2018 B2
9891079 Dalvi Feb 2018 B2
9895107 Al-Ali et al. Feb 2018 B2
9913617 Al-Ali et al. Mar 2018 B2
9924893 Schurman et al. Mar 2018 B2
9924897 Abdul-Hafiz Mar 2018 B1
9936917 Poeze et al. Apr 2018 B2
9943269 Muhsin et al. Apr 2018 B2
9949676 Al-Ali Apr 2018 B2
9955937 Telfort May 2018 B2
9965946 Al-Ali May 2018 B2
9980667 Kiani et al. May 2018 B2
D820865 Muhsin et al. Jun 2018 S
9986919 Lamego et al. Jun 2018 B2
9986952 Dalvi et al. Jun 2018 B2
9989560 Poeze et al. Jun 2018 B2
9993207 Al-Ali et al. Jun 2018 B2
10007758 Al-Ali et al. Jun 2018 B2
D822215 Al-Ali et al. Jul 2018 S
D822216 Barker et al. Jul 2018 S
10010276 Al-Ali et al. Jul 2018 B2
10032002 Kiani et al. Jul 2018 B2
10039482 Al-Ali et al. Aug 2018 B2
10052037 Kinast et al. Aug 2018 B2
10058275 Al-Ali et al. Aug 2018 B2
10064562 Al-Ali Sep 2018 B2
10086138 Novak, Jr. Oct 2018 B1
10092200 Al-Ali et al. Oct 2018 B2
10092249 Kiani et al. Oct 2018 B2
10098550 Al-Ali et al. Oct 2018 B2
10098591 Al-Ali et al. Oct 2018 B2
10098610 Al-Ali et al. Oct 2018 B2
10111591 Dyell et al. Oct 2018 B2
D833624 DeJong et al. Nov 2018 S
10123726 Al-Ali et al. Nov 2018 B2
10123729 Dyell et al. Nov 2018 B2
10130289 Al-Ali et al. Nov 2018 B2
10130291 Schurman et al. Nov 2018 B2
D835282 Barker et al. Dec 2018 S
D835283 Barker et al. Dec 2018 S
D835284 Barker et al. Dec 2018 S
D835285 Barker et al. Dec 2018 S
10149616 Al-Ali et al. Dec 2018 B2
10154815 Al-Ali et al. Dec 2018 B2
10159412 Lamego et al. Dec 2018 B2
10188296 Al-Ali et al. Jan 2019 B2
10188331 Al-Ali et al. Jan 2019 B1
10188348 Kiani et al. Jan 2019 B2
RE47218 Ali-Ali Feb 2019 E
RE47244 Kiani et al. Feb 2019 E
RE47249 Kiani et al. Feb 2019 E
10194847 Al-Ali Feb 2019 B2
10194848 Kiani et al. Feb 2019 B1
10201298 Al-Ali et al. Feb 2019 B2
10205272 Kiani et al. Feb 2019 B2
10205291 Scruggs et al. Feb 2019 B2
10213108 Al-Ali Feb 2019 B2
10219706 Al-Ali Mar 2019 B2
10219746 McHale et al. Mar 2019 B2
10226187 Al-Ali et al. Mar 2019 B2
10226576 Kiani Mar 2019 B2
10231657 Al-Ali et al. Mar 2019 B2
10231670 Blank et al. Mar 2019 B2
10231676 Al-Ali et al. Mar 2019 B2
RE47353 Kiani et al. Apr 2019 E
10251585 Al-Ali et al. Apr 2019 B2
10251586 Lamego Apr 2019 B2
10255994 Sampath et al. Apr 2019 B2
10258265 Poeze et al. Apr 2019 B1
10258266 Poeze et al. Apr 2019 B1
10271748 Al-Ali Apr 2019 B2
10278626 Schurman et al. May 2019 B2
10278648 Al-Ali et al. May 2019 B2
10279247 Kiani May 2019 B2
10292628 Poeze et al. May 2019 B1
10292657 Abdul-Hafiz et al. May 2019 B2
10292664 Al-Ali May 2019 B2
10299708 Poeze et al. May 2019 B1
10299709 Perea et al. May 2019 B2
10299720 Brown et al. May 2019 B2
10305775 Lamego et al. May 2019 B2
10307111 Muhsin et al. Jun 2019 B2
10325681 Sampath et al. Jun 2019 B2
10327337 Triman et al. Jun 2019 B2
10327713 Barker et al. Jun 2019 B2
10332630 Al-Ali Jun 2019 B2
10383520 Wojtczuk et al. Aug 2019 B2
10383527 Al-Ali Aug 2019 B2
10388120 Muhsin et al. Aug 2019 B2
D864120 Forrest et al. Oct 2019 S
10441181 Telfort et al. Oct 2019 B1
10441196 Eckerbom et al. Oct 2019 B2
10448844 Al-Ali et al. Oct 2019 B2
10448871 Al-Ali et al. Oct 2019 B2
10456038 Lamego et al. Oct 2019 B2
10463340 Telfort et al. Nov 2019 B2
10471159 Lapotko et al. Nov 2019 B1
10505311 Al-Ali et al. Dec 2019 B2
10524738 Olsen Jan 2020 B2
10532174 Al-Ali Jan 2020 B2
10537285 Shreim et al. Jan 2020 B2
10542903 Al-Ali et al. Jan 2020 B2
10555678 Dalvi et al. Feb 2020 B2
10568553 O'Neil et al. Feb 2020 B2
RE47882 Al-Ali Mar 2020 E
10608817 Haider et al. Mar 2020 B2
D880477 Forrest et al. Apr 2020 S
10617302 Al-Ali et al. Apr 2020 B2
10617335 Al-Ali et al. Apr 2020 B2
10637181 Al-Ali et al. Apr 2020 B2
D887548 Abdul-Hafiz et al. Jun 2020 S
D887549 Abdul-Hafiz et al. Jun 2020 S
10667764 Ahmed et al. Jun 2020 B2
D890708 Forrest et al. Jul 2020 S
10721785 Al-Ali Jul 2020 B2
10736518 Al-Ali et al. Aug 2020 B2
10750984 Pauley et al. Aug 2020 B2
D897098 Al-Ali Sep 2020 S
10779098 Iswanto et al. Sep 2020 B2
10827961 Iyengar et al. Nov 2020 B1
10828007 Telfort et al. Nov 2020 B1
10832818 Muhsin et al. Nov 2020 B2
10849554 Shreim et al. Dec 2020 B2
10856750 Indorf Dec 2020 B2
D906970 Forrest et al. Jan 2021 S
10918281 Al-Ali et al. Feb 2021 B2
10932705 Muhsin et al. Mar 2021 B2
10932729 Kiani et al. Mar 2021 B2
10939878 Kiani et al. Mar 2021 B2
10956950 Al-Ali et al. Mar 2021 B2
D916135 Indorf et al. Apr 2021 S
D917550 Indorf et al. Apr 2021 S
D917564 Indorf et al. Apr 2021 S
D917704 Al-Ali et al. Apr 2021 S
10987066 Chandran et al. Apr 2021 B2
10991135 Al-Ali et al. Apr 2021 B2
D919094 Al-Ali et al. May 2021 S
D919100 Al-Ali et al. May 2021 S
11006867 Al-Ali May 2021 B2
D921202 Al-Ali et al. Jun 2021 S
11024064 Muhsin et al. Jun 2021 B2
11026604 Chen et al. Jun 2021 B2
D925597 Chandran et al. Jul 2021 S
D927699 Al-Ali et al. Aug 2021 S
11076777 Lee et al. Aug 2021 B2
11114188 Poeze et al. Sep 2021 B2
D933232 Al-Ali et al. Oct 2021 S
11145408 Sampath et al. Oct 2021 B2
11147518 Al-Ali et al. Oct 2021 B1
11185262 Al-Ali et al. Nov 2021 B2
11191484 Kiani et al. Dec 2021 B2
D946596 Ahmed Mar 2022 S
D946597 Ahmed Mar 2022 S
D946598 Ahmed Mar 2022 S
D946617 Ahmed Mar 2022 S
11272839 Al-Ali et al. Mar 2022 B2
11289199 Al-Ali Mar 2022 B2
RE49034 Al-Ali Apr 2022 E
11298021 Muhsin et al. Apr 2022 B2
D950580 Ahmed May 2022 S
D950599 Ahmed May 2022 S
20010034477 Mansfield et al. Oct 2001 A1
20010039483 Brand et al. Nov 2001 A1
20020010401 Bushmakin et al. Jan 2002 A1
20020019707 Cohen Feb 2002 A1
20020058864 Mansfield et al. May 2002 A1
20020133080 Apruzzese et al. Sep 2002 A1
20020178126 Beck Nov 2002 A1
20030013975 Kiani Jan 2003 A1
20030018243 Gerhardt et al. Jan 2003 A1
20030144582 Cohen et al. Jul 2003 A1
20030156288 Barnum et al. Aug 2003 A1
20030212312 Coffin, IV et al. Nov 2003 A1
20040106163 Workman, Jr. et al. Jun 2004 A1
20050055276 Kiani et al. Mar 2005 A1
20050234317 Kiani Oct 2005 A1
20060073719 Kiani Apr 2006 A1
20060161054 Reuss et al. Jul 2006 A1
20060189871 Al-Ali et al. Aug 2006 A1
20070027382 Berman Feb 2007 A1
20070073116 Kiani et al. Mar 2007 A1
20070180140 Welch et al. Aug 2007 A1
20070244377 Cozad et al. Oct 2007 A1
20070265514 Kiani Nov 2007 A1
20070282478 Al-Ali et al. Dec 2007 A1
20080064965 Jay et al. Mar 2008 A1
20080094228 Welch et al. Apr 2008 A1
20080221418 Al-Ali et al. Sep 2008 A1
20080288180 Hayter Nov 2008 A1
20090036759 Ault et al. Feb 2009 A1
20090093687 Telfort et al. Apr 2009 A1
20090095926 MacNeish, III Apr 2009 A1
20090247924 Lamego et al. Oct 2009 A1
20090247984 Lamego et al. Oct 2009 A1
20090275813 Davis Nov 2009 A1
20090275844 Al-Ali Nov 2009 A1
20090299157 Telfort et al. Dec 2009 A1
20100004518 Vo et al. Jan 2010 A1
20100030040 Poeze et al. Feb 2010 A1
20100069725 Al-Ali Mar 2010 A1
20100099964 O'Reilly et al. Apr 2010 A1
20100223020 Goetz Sep 2010 A1
20100234718 Sampath et al. Sep 2010 A1
20100261979 Kiani Oct 2010 A1
20100270257 Wachman et al. Oct 2010 A1
20100317936 Al-Ali et al. Dec 2010 A1
20110001605 Kiani et al. Jan 2011 A1
20110028806 Merritt et al. Feb 2011 A1
20110028809 Goodman Feb 2011 A1
20110040197 Welch et al. Feb 2011 A1
20110082711 Poeze et al. Apr 2011 A1
20110087081 Kiani et al. Apr 2011 A1
20110105854 Kiani et al. May 2011 A1
20110118561 Tari et al. May 2011 A1
20110125060 Telfort et al. May 2011 A1
20110137297 Kiani et al. Jun 2011 A1
20110172498 Olsen et al. Jul 2011 A1
20110172967 Al-Ali et al. Jul 2011 A1
20110208015 Welch et al. Aug 2011 A1
20110209915 Telfort et al. Sep 2011 A1
20110213212 Al-Ali Sep 2011 A1
20110230733 Al-Ali Sep 2011 A1
20110237911 Lamego et al. Sep 2011 A1
20120059267 Lamego et al. Mar 2012 A1
20120116175 Al-Ali et al. May 2012 A1
20120123231 O'Reilly May 2012 A1
20120165629 Merritt et al. Jun 2012 A1
20120179006 Jansen et al. Jul 2012 A1
20120209082 Al-Ali Aug 2012 A1
20120209084 Olsen et al. Aug 2012 A1
20120226117 Lamego et al. Sep 2012 A1
20120227739 Kiani Sep 2012 A1
20120283524 Kiani et al. Nov 2012 A1
20120286955 Welch et al. Nov 2012 A1
20120302894 Diab et al. Nov 2012 A1
20120319816 Al-Ali Dec 2012 A1
20130023775 Lamego et al. Jan 2013 A1
20130041591 Lamego Feb 2013 A1
20130045685 Kiani Feb 2013 A1
20130060147 Welch et al. Mar 2013 A1
20130096405 Garfio Apr 2013 A1
20130296672 O'Neil et al. Nov 2013 A1
20130296713 Al-Ali et al. Nov 2013 A1
20130331660 Al-Ali et al. Dec 2013 A1
20130345921 Al-Ali et al. Dec 2013 A1
20140166076 Kiani et al. Jun 2014 A1
20140180160 Brown et al. Jun 2014 A1
20140187973 Brown et al. Jul 2014 A1
20140275871 Lamego et al. Sep 2014 A1
20140275872 Merritt et al. Sep 2014 A1
20140276115 Dalvi et al. Sep 2014 A1
20140316217 Purdon et al. Oct 2014 A1
20140316218 Purdon et al. Oct 2014 A1
20140323897 Brown et al. Oct 2014 A1
20140323898 Purdon et al. Oct 2014 A1
20140357966 Al-Ali et al. Dec 2014 A1
20150005600 Blank et al. Jan 2015 A1
20150011907 Purdon et al. Jan 2015 A1
20150012231 Poeze et al. Jan 2015 A1
20150032029 Al-Ali et al. Jan 2015 A1
20150038859 Dalvi et al. Feb 2015 A1
20150073241 Lamego Mar 2015 A1
20150080754 Purdon et al. Mar 2015 A1
20150087936 Al-Ali et al. Mar 2015 A1
20150094546 Al-All Apr 2015 A1
20150097701 Al-Ali et al. Apr 2015 A1
20150099950 Al-Ali et al. Apr 2015 A1
20150099955 Al-Ali et al. Apr 2015 A1
20150101844 Al-Ali et al. Apr 2015 A1
20150106121 Muhsin et al. Apr 2015 A1
20150112151 Muhsin et al. Apr 2015 A1
20150116076 Al-Ali et al. Apr 2015 A1
20150165312 Kiani Jun 2015 A1
20150196249 Brown et al. Jul 2015 A1
20150216459 Al-Ali et al. Aug 2015 A1
20150238722 Al-All Aug 2015 A1
20150245773 Lamego et al. Sep 2015 A1
20150245794 Al-Ali Sep 2015 A1
20150257689 Al-Ali et al. Sep 2015 A1
20150272514 Kiani et al. Oct 2015 A1
20150351697 Weber et al. Dec 2015 A1
20150359429 Al-Ali et al. Dec 2015 A1
20150366507 Blank Dec 2015 A1
20160029932 Al-Ali Feb 2016 A1
20160058347 Reichgott et al. Mar 2016 A1
20160066824 Al-Ali et al. Mar 2016 A1
20160081552 Wojtczuk et al. Mar 2016 A1
20160095543 Telfort et al. Apr 2016 A1
20160095548 Al-Ali et al. Apr 2016 A1
20160103598 Al-Ali et al. Apr 2016 A1
20160143548 Al-All May 2016 A1
20160166182 Al-Ali et al. Jun 2016 A1
20160166183 Poeze et al. Jun 2016 A1
20160192869 Kiani et al. Jul 2016 A1
20160197436 Barker et al. Jul 2016 A1
20160213281 Eckerbom et al. Jul 2016 A1
20160228043 O'Neil et al. Aug 2016 A1
20160233632 Scruggs et al. Aug 2016 A1
20160234944 Schmidt et al. Aug 2016 A1
20160270735 Diab et al. Sep 2016 A1
20160283665 Sampath et al. Sep 2016 A1
20160287090 Al-Ali et al. Oct 2016 A1
20160287786 Kiani Oct 2016 A1
20160296169 McHale et al. Oct 2016 A1
20160310052 Al-Ali et al. Oct 2016 A1
20160314260 Kiani Oct 2016 A1
20160324486 Al-Ali et al. Nov 2016 A1
20160324488 Olsen Nov 2016 A1
20160327984 Al-Ali et al. Nov 2016 A1
20160328528 Al-Ali et al. Nov 2016 A1
20160331332 Al-Ali Nov 2016 A1
20160367173 Dalvi et al. Dec 2016 A1
20170000394 Al-Ali et al. Jan 2017 A1
20170007134 Al-Ali et al. Jan 2017 A1
20170007198 Al-Ali et al. Jan 2017 A1
20170014083 Diab et al. Jan 2017 A1
20170014084 Al-Ali et al. Jan 2017 A1
20170024748 Haider Jan 2017 A1
20170027456 Kinast et al. Feb 2017 A1
20170042488 Muhsin Feb 2017 A1
20170055851 Al-Ali Mar 2017 A1
20170055882 Al-Ali et al. Mar 2017 A1
20170055887 Al-All Mar 2017 A1
20170055896 Al-Ali et al. Mar 2017 A1
20170079594 Telfort et al. Mar 2017 A1
20170086723 Al-Ali et al. Mar 2017 A1
20170143281 Olsen May 2017 A1
20170147774 Kiani May 2017 A1
20170156620 Al-Ali et al. Jun 2017 A1
20170173632 Al-Ali Jun 2017 A1
20170187146 Kiani et al. Jun 2017 A1
20170188919 Al-Ali et al. Jul 2017 A1
20170196464 Jansen et al. Jul 2017 A1
20170196470 Lamego et al. Jul 2017 A1
20170202490 Al-Ali et al. Jul 2017 A1
20170224262 Al-Ali Aug 2017 A1
20170228516 Sampath et al. Aug 2017 A1
20170245790 Al-Ali et al. Aug 2017 A1
20170251974 Shreim et al. Sep 2017 A1
20170251975 Shreim et al. Sep 2017 A1
20170258403 Abdul-Hafiz et al. Sep 2017 A1
20170311851 Schurman et al. Nov 2017 A1
20170311891 Kiani et al. Nov 2017 A1
20170325728 Al-Ali et al. Nov 2017 A1
20170332976 Al-Ali et al. Nov 2017 A1
20170340293 Al-Ali et al. Nov 2017 A1
20170360310 Kiani et al. Dec 2017 A1
20170367632 Al-Ali et al. Dec 2017 A1
20180008146 Al-Ali et al. Jan 2018 A1
20180013562 Haider et al. Jan 2018 A1
20180014752 Al-Ali et al. Jan 2018 A1
20180028124 Al-Ali et al. Feb 2018 A1
20180055385 Al-Ali Mar 2018 A1
20180055390 Kiani et al. Mar 2018 A1
20180055430 Diab et al. Mar 2018 A1
20180064381 Shakespeare et al. Mar 2018 A1
20180069776 Lamego et al. Mar 2018 A1
20180070867 Smith et al. Mar 2018 A1
20180082767 Al-Ali et al. Mar 2018 A1
20180085068 Telfort Mar 2018 A1
20180087937 Al-Ali et al. Mar 2018 A1
20180103874 Lee et al. Apr 2018 A1
20180103905 Kiani Apr 2018 A1
20180110478 Al-Ali Apr 2018 A1
20180116575 Perea et al. May 2018 A1
20180125368 Lamego et al. May 2018 A1
20180125430 Al-Ali et al. May 2018 A1
20180125445 Telfort et al. May 2018 A1
20180130325 Kiani et al. May 2018 A1
20180132769 Weber et al. May 2018 A1
20180132770 Lamego May 2018 A1
20180146901 Al-Ali et al. May 2018 A1
20180146902 Kiani et al. May 2018 A1
20180153442 Eckerbom et al. Jun 2018 A1
20180153446 Kiani Jun 2018 A1
20180153447 Al-Ali et al. Jun 2018 A1
20180153448 Weber et al. Jun 2018 A1
20180161499 Al-Ali et al. Jun 2018 A1
20180168491 Al-Ali et al. Jun 2018 A1
20180174679 Sampath et al. Jun 2018 A1
20180174680 Sampath et al. Jun 2018 A1
20180182484 Sampath et al. Jun 2018 A1
20180184917 Kiani Jul 2018 A1
20180192924 Al-Ali Jul 2018 A1
20180192953 Shreim et al. Jul 2018 A1
20180192955 Al-Ali et al. Jul 2018 A1
20180199871 Pauley et al. Jul 2018 A1
20180206795 Al-Ali Jul 2018 A1
20180206815 Telfort Jul 2018 A1
20180213583 Al-Ali Jul 2018 A1
20180214031 Kiani et al. Aug 2018 A1
20180214090 Al-Ali et al. Aug 2018 A1
20180218792 Muhsin et al. Aug 2018 A1
20180225960 Al-Ali et al. Aug 2018 A1
20180238718 Dalvi Aug 2018 A1
20180242853 Al-Ali Aug 2018 A1
20180242921 Muhsin et al. Aug 2018 A1
20180242923 Al-Ali et al. Aug 2018 A1
20180242924 Barker et al. Aug 2018 A1
20180242926 Muhsin et al. Aug 2018 A1
20180247353 Al-Ali et al. Aug 2018 A1
20180247712 Muhsin et al. Aug 2018 A1
20180249933 Schurman et al. Sep 2018 A1
20180253947 Muhsin et al. Sep 2018 A1
20180256087 Al-Ali et al. Sep 2018 A1
20180256113 Weber et al. Sep 2018 A1
20180285094 Housel et al. Oct 2018 A1
20180289325 Poeze et al. Oct 2018 A1
20180289337 Al-Ali et al. Oct 2018 A1
20180296161 Shreim et al. Oct 2018 A1
20180300919 Muhsin et al. Oct 2018 A1
20180310822 Indorf et al. Nov 2018 A1
20180310823 Al-Ali et al. Nov 2018 A1
20180317826 Muhsin Nov 2018 A1
20180317841 Novak, Jr. Nov 2018 A1
20180333055 Lamego et al. Nov 2018 A1
20180333087 Al-Ali Nov 2018 A1
20190000317 Muhsin et al. Jan 2019 A1
20190000362 Kiani et al. Jan 2019 A1
20190015023 Monfre Jan 2019 A1
20190021638 Al-Ali et al. Jan 2019 A1
20190029574 Schurman et al. Jan 2019 A1
20190029578 Al-Ali et al. Jan 2019 A1
20190058280 Al-Ali et al. Feb 2019 A1
20190058281 Al-Ali et al. Feb 2019 A1
20190069813 Al-Ali Mar 2019 A1
20190069814 Al-Ali Mar 2019 A1
20190076028 Al-Ali et al. Mar 2019 A1
20190082979 Al-Ali et al. Mar 2019 A1
20190090748 Al-Ali Mar 2019 A1
20190090760 Kinast et al. Mar 2019 A1
20190090764 Al-Ali Mar 2019 A1
20190117070 Muhsin et al. Apr 2019 A1
20190117139 Al-Ali et al. Apr 2019 A1
20190117140 Al-Ali et al. Apr 2019 A1
20190117141 Al-Ali Apr 2019 A1
20190117930 Al-Ali Apr 2019 A1
20190122763 Sampath et al. Apr 2019 A1
20190133525 Al-Ali et al. May 2019 A1
20190142283 Lamego et al. May 2019 A1
20190142344 Telfort et al. May 2019 A1
20190150856 Kiani et al. May 2019 A1
20190167161 Al-Ali et al. Jun 2019 A1
20190175019 Al-Ali et al. Jun 2019 A1
20190192076 McHale et al. Jun 2019 A1
20190200941 Chandran et al. Jul 2019 A1
20190239787 Pauley et al. Aug 2019 A1
20190320906 Olsen Oct 2019 A1
20190374139 Kiani et al. Dec 2019 A1
20190374173 Kiani et al. Dec 2019 A1
20190374713 Kiani et al. Dec 2019 A1
20200060869 Telfort et al. Feb 2020 A1
20200111552 Ahmed Apr 2020 A1
20200113435 Muhsin Apr 2020 A1
20200113488 Al-Ali et al. Apr 2020 A1
20200113496 Scruggs et al. Apr 2020 A1
20200113497 Triman et al. Apr 2020 A1
20200113520 Abdul-Hafiz et al. Apr 2020 A1
20200138288 Al-Ali et al. May 2020 A1
20200138368 Kiani et al. May 2020 A1
20200163597 Dalvi et al. May 2020 A1
20200196877 Vo et al. Jun 2020 A1
20200253474 Muhsin et al. Aug 2020 A1
20200253544 Belur Nagaraj et al. Aug 2020 A1
20200275841 Telfort et al. Sep 2020 A1
20200288983 Telfort et al. Sep 2020 A1
20200321793 Al-Ali et al. Oct 2020 A1
20200329983 Al-Ali et al. Oct 2020 A1
20200329984 Al-Ali et al. Oct 2020 A1
20200329993 Al-Ali et al. Oct 2020 A1
20200330037 Al-Ali et al. Oct 2020 A1
20210022628 Telfort et al. Jan 2021 A1
20210104173 Pauley et al. Apr 2021 A1
20210113121 Diab et al. Apr 2021 A1
20210117525 Kiani et al. Apr 2021 A1
20210118581 Kiani et al. Apr 2021 A1
20210121582 Krishnamani et al. Apr 2021 A1
20210161465 Barker et al. Jun 2021 A1
20210236729 Kiani et al. Aug 2021 A1
20210256267 Ranasinghe et al. Aug 2021 A1
20210256835 Ranasinghe et al. Aug 2021 A1
20210275101 Vo et al. Sep 2021 A1
20210290060 Ahmed Sep 2021 A1
20210290072 Forrest Sep 2021 A1
20210290080 Ahmed Sep 2021 A1
20210290120 Al-Ali Sep 2021 A1
20210290177 Novak, Jr. Sep 2021 A1
20210290184 Ahmed Sep 2021 A1
20210296008 Novak, Jr. Sep 2021 A1
20210330228 Olsen et al. Oct 2021 A1
20210386382 Olsen et al. Dec 2021 A1
20210402110 Pauley et al. Dec 2021 A1
20220026355 Normand et al. Jan 2022 A1
20220039707 Sharma et al. Feb 2022 A1
20220053892 Al-Ali et al. Feb 2022 A1
20220071562 Kiani Mar 2022 A1
20220096603 Kiani et al. Mar 2022 A1
20220151521 Krishnamani et al. May 2022 A1
Foreign Referenced Citations (1)
Number Date Country
WO 2015038683 Mar 2015 WO
Non-Patent Literature Citations (5)
Entry
US 2022/0192529 A1, 06/2022, Al-Ali et al. (withdrawn)
Sandeep Kumar Vashist, Non-invasive glucose monitoring technology in diabetes management: A review, Analytica Chimica Acta 750 (2012) 16-27 (Year: 2012).
Wikipedia, XML, Jan. 22, 2003, pp. 1-3 (Year: 2003).
International Search Report for International Application No. PCT/US2014/055042, dated Mar. 31, 2015.
Invitation to Pay Additional dated Dec. 3, 2014, International Application No. PCT/US2014/055042, filed Sep. 10, 2014.
Related Publications (1)
Number Date Country
20160196388 A1 Jul 2016 US
Provisional Applications (1)
Number Date Country
61877181 Sep 2013 US
Continuations (1)
Number Date Country
Parent PCT/US2014/055042 Sep 2014 US
Child 15067061 US